Paracetamol + Diphenhydramine hydrochloride
This medicine should always be used exactly as described in the patient leaflet or as directed by a doctor or pharmacist.
APAP Noc is a pain reliever and antipyretic that combines the action of paracetamol with the sedative and hypnotic action of diphenhydramine. It relieves pain, facilitates falling asleep, and prevents nighttime awakenings caused by pain.
The indication for use is short-term treatment of pain, including: headache, musculoskeletal pain, muscle pain, toothache, menstrual pain, neuralgia, pain associated with colds and flu, causing difficulty falling asleep.
Before starting to use APAP Noc, you should discuss it with your doctor or pharmacist.
During the use of APAP Noc, you should immediately inform your doctor if:
Use in children under 12 years of age is contraindicated.
You should tell your doctor or pharmacist about all medicines the patient is currently taking or has recently taken, as well as any medicines the patient plans to take.
APAP Noc should not be used at the same time as other medicines containing paracetamol and diphenhydramine.
In the case of concurrent use of anticoagulant medicines (warfarin and other coumarin derivatives), medicines acting depressively on the central nervous system (such as sleeping pills, sedatives, and opioid painkillers), neuroleptic medicines (used in states of excessive excitement), antidepressant medicines (fluoxetine, paroxetine, tricyclic antidepressants), antiepileptic medicines (phenytoin, carbamazepine, phenobarbital), and rifampicin (an antibiotic used, among other things, in the treatment of tuberculosis) - before taking the medicine, you should consult a doctor.
You should inform your doctor or pharmacist if the patient is taking:
The medicine contains less than 1 mmol (23 mg) of sodium per single dose (1-2 tablets), which means the medicine is considered "sodium-free".
Food does not reduce the absorption of the medicine.
If the patient is pregnant or breastfeeding, suspects they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before using this medicine.
The medicine should not be used in pregnant and breastfeeding women.
While using the medicine, you should not drive vehicles or operate machinery in motion.
This medicine should always be used exactly as described in the patient leaflet or as directed by a doctor or pharmacist.
In case of doubts, you should consult a doctor or pharmacist.
Oral administration. Use only before bedtime.
Adults and adolescents from 16 years of age: 1 or 2 tablets 30 minutes before bedtime. Do not take more than 2 tablets per day.
Adolescents from 12 to 15 years of age: 1 tablet 30 minutes before bedtime. Do not take more than 1 tablet per day.
Do not take a dose larger than recommended.
Long-term use without medical supervision may be harmful. Do not use the medicine for more than 7 days without consulting a doctor.
In case of persistent symptoms, you should contact your doctor.
Administration of the medicine to children under 12 years of age is contraindicated.
Severe nausea, vomiting, excessive sweating, drowsiness, and general weakness may occur.
These symptoms may resolve the next day, despite the fact that liver damage is beginning to develop, which will later manifest as abdominal distension, return of nausea, and jaundice.
Due to the risk of irreversible liver damage in case of overdose, you should immediately contact a doctor.
Do not take a double dose to make up for a missed dose.
In case of any further doubts related to the use of this medicine, you should consult a doctor or pharmacist.
Like all medicines, APAP Noc can cause side effects, although not everybody gets them.
They include:
uncommon side effects (between 1 in 100 and 1 in 1,000 people using the medicine):
rare side effects (between 1 in 1,000 and 1 in 10,000 people using the medicine):
side effects with unknown frequency (cannot be estimated from available data):
If you experience any side effects, including any possible side effects not listed in this leaflet, you should tell your doctor or pharmacist.
Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C
02-222 Warsaw
tel.: +48 (22) 49 21 301
fax: +48 (22) 49 21 309
website: https://smz.ezdrowie.gov.pl/
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help gather more information on the safety of the medicine.
Store the medicine at a temperature below 30°C.
Keep out of sight and reach of children.
Store the blister in the outer packaging to protect from light.
Do not use the medicine after the expiry date stated on the carton and inner packaging (month/year).
The applied labeling for the blister is: EXP - expiry date; Lot - batch number.
The expiry date means the last day of the given month.
Medicines should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
The active substances of the medicine are:
Paracetamol
500 mg
Diphenhydramine hydrochloride
25 mg
The other ingredients are:
tablet core:pregelatinized starch, povidone, crospovidone, stearic acid, microcrystalline cellulose, sodium carboxymethylcellulose, magnesium stearate, cornstarch, brilliant blue, lake (E 133);
coating:Opadry Blue YS-1-10524 (hypromellose, titanium dioxide (E 171), macrogol 400, brilliant blue, lake (E 133), polysorbate 80, carmine (E 132));
coating:colorless coating (hypromellose, macrogol 400, macrogol 8000).
Blue, elongated, coated tablets with the inscription "APAP N" embossed on one side; intended for oral administration, packaged in blisters or bottles and cartons with a leaflet.
6, 12, 24 tablets in blisters and 50 tablets in a bottle.
Not all pack sizes may be marketed.
US Pharmacia Sp. z o.o.
ul. Ziębicka 40
50-507 Wrocław
To obtain more detailed information about this medicine, you should contact:
USP Zdrowie Sp. z o.o.
ul. Poleczki 35
02-822 Warsaw
tel.: +48 (22) 543 60 00
Date of last revision of the leaflet:
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.